128 related articles for article (PubMed ID: 36889654)
1. Evaluation of the
Willuweit A; Humpert S; Schöneck M; Endepols H; Burda N; Gremer L; Gering I; Kutzsche J; Shah NJ; Langen KJ; Neumaier B; Willbold D; Drzezga A
Eur J Pharm Sci; 2023 May; 184():106421. PubMed ID: 36889654
[TBL] [Abstract][Full Text] [Related]
2. Preclinical and clinical study on [
Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345
[TBL] [Abstract][Full Text] [Related]
3. High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain.
Fang XT; Hultqvist G; Meier SR; Antoni G; Sehlin D; Syvänen S
Neuroimage; 2019 Jan; 184():881-888. PubMed ID: 30300753
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and preliminary evaluation of [
He Y; Zhu X; Wang K; Xie J; Zhu Z; Ni M; Wang S; Xie Q
Bioorg Med Chem; 2022 Dec; 75():117087. PubMed ID: 36356533
[TBL] [Abstract][Full Text] [Related]
5. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.
Choi SR; Golding G; Zhuang Z; Zhang W; Lim N; Hefti F; Benedum TE; Kilbourn MR; Skovronsky D; Kung HF
J Nucl Med; 2009 Nov; 50(11):1887-94. PubMed ID: 19837759
[TBL] [Abstract][Full Text] [Related]
6. Engineering of donor-acceptor-donor curcumin analogues as near-infrared fluorescent probes for
Fang D; Wen X; Wang Y; Sun Y; An R; Zhou Y; Ye D; Liu H
Theranostics; 2022; 12(7):3178-3195. PubMed ID: 35547754
[TBL] [Abstract][Full Text] [Related]
7. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
[TBL] [Abstract][Full Text] [Related]
8. Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition.
Meier SR; Syvänen S; Hultqvist G; Fang XT; Roshanbin S; Lannfelt L; Neumann U; Sehlin D
J Nucl Med; 2018 Dec; 59(12):1885-1891. PubMed ID: 29853653
[TBL] [Abstract][Full Text] [Related]
9. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.
Klunk WE; Lopresti BJ; Ikonomovic MD; Lefterov IM; Koldamova RP; Abrahamson EE; Debnath ML; Holt DP; Huang GF; Shao L; DeKosky ST; Price JC; Mathis CA
J Neurosci; 2005 Nov; 25(46):10598-606. PubMed ID: 16291932
[TBL] [Abstract][Full Text] [Related]
10. Deceleration of the neurodegenerative phenotype in pyroglutamate-Aβ accumulating transgenic mice by oral treatment with the Aβ oligomer eliminating compound RD2.
Schemmert S; Schartmann E; Honold D; Zafiu C; Ziehm T; Langen KJ; Shah NJ; Kutzsche J; Willuweit A; Willbold D
Neurobiol Dis; 2019 Apr; 124():36-45. PubMed ID: 30391539
[TBL] [Abstract][Full Text] [Related]
11.
Fang D; Pan D; Wen X; Zhang J; Yang M; Ye D; Liu H
ACS Chem Neurosci; 2024 Feb; 15(3):472-478. PubMed ID: 38214485
[TBL] [Abstract][Full Text] [Related]
12. [
Nguyen GAH; Liang C; Mukherjee J
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889425
[TBL] [Abstract][Full Text] [Related]
13. Conversion of iodine to fluorine-18 based on iodinated chalcone and evaluation for β-amyloid PET imaging.
Kaide S; Ono M; Watanabe H; Shimizu Y; Nakamoto Y; Togashi K; Yamaguchi A; Hanaoka H; Saji H
Bioorg Med Chem; 2018 Jul; 26(12):3352-3358. PubMed ID: 29751990
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 11C-labeled imidazo[2,1-b]benzothiazoles (IBTs) as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.
Yousefi BH; Manook A; Drzezga A; von Reutern B; Schwaiger M; Wester HJ; Henriksen G
J Med Chem; 2011 Feb; 54(4):949-56. PubMed ID: 21275403
[TBL] [Abstract][Full Text] [Related]
16.
Meier SR; Sehlin D; Roshanbin S; Falk VL; Saito T; Saido TC; Neumann U; Rokka J; Eriksson J; Syvänen S
J Nucl Med; 2022 Feb; 63(2):302-309. PubMed ID: 34088777
[TBL] [Abstract][Full Text] [Related]
17. Fluorine-19 Magnetic Resonance Imaging for Detection of Amyloid β Oligomers Using a Keto Form of Curcumin Derivative in a Mouse Model of Alzheimer's Disease.
Yanagisawa D; Ibrahim NF; Taguchi H; Morikawa S; Tomiyama T; Tooyama I
Molecules; 2021 Mar; 26(5):. PubMed ID: 33806326
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of [¹⁸F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease.
Snellman A; Rokka J; Lopez-Picon FR; Eskola O; Wilson I; Farrar G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1784-95. PubMed ID: 22801729
[TBL] [Abstract][Full Text] [Related]
19. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP
J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073
[TBL] [Abstract][Full Text] [Related]
20. [
Maruyama H; Gomi M; Lwin TT; Yoneyama A; Sasaki T
Ann Nucl Med; 2024 Feb; 38(2):120-130. PubMed ID: 37921921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
